rs532007878
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_001277115.2(DNAH11):c.4095+2C>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001277115.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00 AC: 0AN: 246968 AF XY: 0.00
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1456820Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 724692
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:2Uncertain:1
- -
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 580732). Disruption of this splice site has been observed in individual(s) with primary ciliary dyskinesia (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 22 of the DNAH11 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DNAH11 are known to be pathogenic (PMID: 18022865, 20513915, 22184204). -
The c.4095+2C>A intronic variant results from a C to A substitution two nucleotides after coding exon 22 in the DNAH11 gene. This variant was detected in the homozygous state in individuals with clinical diagnosis of primary ciliary dyskinesia (Ambry internal data). This nucleotide position is highly conserved in available vertebrate species. Using the ESEfinder splice site prediction tool, this alteration is predicted to abolish the native splice donor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
DNAH11-related disorder Pathogenic:1
The DNAH11 c.4095+2C>A variant is predicted to interfere with splicing. This variant has not been reported in the literature or in a large population database, indicating this variant is rare. Based on available splicing prediction programs, this variant is predicted to impact the canonical splice donor site of exon 22 of the DNAH11 gene and to interfere with splicing (Alamut Visual Plus v1.6.1; SpliceAI, Jaganathan et al. 2019. PubMed ID: 30661751). Aberrant splicing and subsequent loss-of-function is a known mechanism of disease for the DNAH11 gene. This variant has conflicting interpretations in ClinVar ranging from pathogenic to likely pathogenic to uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/580732/). Of note, this variant has been reported in ClinVar by another laboratory in the homozygous state in a patient with ciliary dyskinesia (https://www.ncbi.nlm.nih.gov/clinvar/variation/580732/). This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at